Figure 4.
Effects of CAFs in CRC. A numeral of biomarkers that are extremely expressed in CAFs, like α-SMA, fibroblast activation protein alpha (FAP), fibroblast-specific protein 1 (FSP-1), platelet-derived growth factor receptor-α (PDGFRα) and PDGFRβ have now been commonly used to classify or isolate CAFs from the pool of fibroblasts present in the whole body. Described genes and proteins showed poorer disease progression, recurrence-free survival, and overall survival. Taken together, these markers could be used as liquid biopsy approach for early detection and treatment prognosis in CRC patients.